Clinical Trial Update: Effect of Acetylcysteine With Topotecan Hydrochloride on the Tumor Microenvironment in Patients With Persistent or Recurrent High Grade Ovarian, Primary Peritoneal, or Fallopian Tube Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating acetylcysteine with topotecan hydrochloride in patients with persistent or recurrent high-grade ovarian, fallopian tube, or primary per…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fallopian Tube Cancer
• Ovarian Cancer
• Peritoneal Cancer

Drugs mentioned

• Acetylcysteine (Acetylcysteine)
• Topotecan hydrochloride (topotecan hydrochloride)

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | Conditions: Malignant Ovarian Endometrioid Tumor, Malignant Ovarian Serous Tumor | Phase 2 | Status: TERMINATED | Results posted: 2018-01-03